학술논문

The role of methylation profiling in histologically diagnosed neurocytoma: a case series
Document Type
article
Source
Journal of Neuro-Oncology. 159(3)
Subject
Brain Disorders
Brain Cancer
Patient Safety
Rare Diseases
Clinical Research
Cancer
Pediatric
4.2 Evaluation of markers and technologies
Detection
screening and diagnosis
Brain Neoplasms
Child
Female
Humans
Ki-67 Antigen
Magnetic Resonance Imaging
Male
Methylation
Neurocytoma
Synaptophysin
Pediatric brain tumor
Pediatric neurocytoma
Atypical neurocytoma
Neurosciences
Oncology and Carcinogenesis
Oncology & Carcinogenesis
Language
Abstract
PurposeTo highlight the clinical, neuroradiographic, neuropathologic, and molecular features of histologically identified neurocytoma in a pediatric cohort and highlight the evolving use methylation profiling in providing diagnostic clarity in difficult to diagnosis pediatric brain tumors.MethodsFive consecutive children (ages 9-13, 2 girls 3 boys) were histologically diagnosed with neurocytoma at Rady Children's Hospital San Diego from 2012 to 2018. Clinical and molecular features were analyzed with regards to treatment course and outcome.ResultsPresenting symptoms included seizures (n = 2), syncope (n = 1), headache (n = 2), visual disturbances (n = 2) and emesis (n = 2). Tumor location included intraventricular (n = 2), intraventricular with parenchymal spread (n = 1), and extraventricular (n = 2). Magnetic resonance imaging demonstrated reduced diffusivity (2/5), signal abnormality on susceptibility-weighted sequences (3/5), and varying degrees of contrast enhancement (4/5). All patients underwent surgical resection alone. Recurrence occurred in four children that were treated with surgery (4/4), adjuvant radiation (2/4), and chemoradiation (1/4). Neuropathologic features included positivity for GFAP (4/5), synaptophysin (4/5), NSE (2/2), NeuN (4/4), and variable Ki-67 (